Management of recurrent colorectal cancer: Another look at carcinoembryonic antigen-detected recurrence

Digestive Diseases

Volumn 14, Issue 1, 1996, Pages 5-13

  Vauthey, J Nicolas ^a   Dudrick, Paul S ^a   Lind, D Scott ^a   Copeland III, Edward M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Carcinoembryonic antigen; Colon cancer; Follow up, colorectal cancer; Prognosis, colorectal cancer; Recurrence, colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

COLORECTAL TUMOR; FOLLOW UP; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; TUMOR RECURRENCE;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 0029685127     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000171535     Document Type: Article

References (48)

1. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
2. Minton JP, Hoehn JL, Gerber DM, et al: Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284-1290.
3. Martin EW Jr, Carey LC: Second-look surgery for colorectal cancer-the second time around. Ann Surg 1991;214:321-327.
4. Torosian MH, Daly JM: CEA-directed second-look surgery; in Cameron JL (ed): Current Surgical Therapy, ed 4. St, Louis, Mosby-Year Book, 1992, pp 203-207.
5. Moertel CG, Fleming TR, Macdonald JS, et al: An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943-947.
6. Kronborg O: Optimal follow-up in colorectal cancer patients: What tests and how often? Semin Surg Oncol 1994;10:217-224.
7. Steele G: Follow-up plans after treatment of primary colon and rectum cancer. World J Surg 1991;15: 583-588.
8. Fletcher RH: Carcinoembryonic antigen. Ann Intern Med 1986;104: 66-73.
9. Benchimoi S, Fuks A, Jothy S, et al: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-334.
10. Pignatelli M, Durbin H, Bodmer WF: Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. Proc Natl Acad Sci USA 1990;87:1541-1545.
11. Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
12. Ewing HP, Newsom BD, Hardy JD: Tumor markers. Curr Probl Surg 1982;19:54-94.
13. Herbeth B, Bagrel A: A study of factors influencing plasma CEA levels in an unselected population. Oncodev Biol Med 1980;1:191-198.
14. Tabor E, Gerety RJ, Needy CF, et al: Carcinoembryonic antigen levels in asymptomatic adolescents. Eur J Cancer 1981;17:257-258.
15. Wangensteen OH: Cancer of the colon with special reference to (1) earlier recognition of alimentary tract malignancy, (2) secondary reentry of the abdomen in patients exhibiting lymph node involvement, (3) subtotal primary excision of the colon, and (4) operation in obstruction. Wis Med J 1949;48:591-597
16. Wangensteen OH, Lewis FJ, Arhelger SW, et al: An interim report upon the 'second look' procedure for cancer of the stomach, colon, and rectum and for 'limited intraperitoneal carcinomatosis'. Surg Gynecol Obstet 1954;99:257-267.
17. Minton JP, Martin EW: The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operation. Cancer 1978;42:1422-1427.
18. Evans JT, Mittelman A, Chu M, Holyoke ED: Pre- and postoperative uses of CEA. Cancer 1978;42:1419-1421.
19. Steele G, Zamcheck N, Wilson R, et al: Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am J Surg 1980;139:544-548.
20. Wanebo HJ: Reoperative surgery for recurrent colorectal cancer: Role of carcinoembryonic antigen in patient selection; in Beahrs OH, Higgins GA, Weinstein JJ (eds): Colorectal Tumors. Philadelphia, Lippincott, 1986, pp 303-313.
21. Michelassi F, Vannucci L, Ayala JJ, et al: Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 1990;108:787-793.
22. Cass AW, Million RR, Pfaff WW: Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976; 37:2861-2865.
23. Gunderson LL, Sosin H: Areas of failure found at reoperation (second or symptomatic look) following 'curative surgery' for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974;34: 1278-1292.
24. Neville AM, Cooper EH: Biochemical monitoring of cancer. Ann Clin Biochem 1976;13:283-305.
25. Wanebo HJ, Marcove HC: Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 1981; 194:458-471.
26. Welch JP, Donaldson GA: The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1979;189:496-502.
27. Heald RJ, Ryall RDH: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;i:1479-1482.
28. Himal HS: Anastomotic recurrence of carcinoma of the colon and rectum. Am Surg 1991;57:334-337.
29. Steele GD, Ravikumar TS: Resection of hepatic metastases from colorectal cancer: Biologic perspectives. Ann Surg 1989;210:127-138.
30. Berge T, Ekelund G, Mellner C, et al: Carcinoma of the colon and rectum in a defined population. Acta Chir Scand 1973;438(suppl):1-86.
31. McCormack PM, Martini N: The changing role of surgery for pulmonary metastases. Ann Thorac Surg 1979;28:139-145.
32. Scheele J, Stangl R, Altendorf-Hofmann A, Gall F: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.
33. McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ: Lung resection for colorectal metastases. Arch Surg 1992;127: 1403-1406.
34. Yeung RS, Moffat FL, Falk RE: Pelvic exenteration for recurrent and extensive primary colorectal adeaocarcinoma. Cancer 1993;72:1853-1858.
35. Vezeridis MP, Wanebo HJ: Extended radical pelvic surgery including sacral resection. Surg Oncol Clin N Am 1994;3:291-305.
36. Sardi A, Minton JP, Nieroda C, Sickle-Santanello B, Young D, Martin EW: Multiple reoperations in recurrent colorectal carcinoma. Cancer 1988;61:1913-1919.
37. Bruinvels DJ, Stiggeibout AM, Kievit J, et al: Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219:174-182.
38. Lefor AT, Hughes KS, Shiloni E, et al: Intra-abdominal extrahepatic disease in patients with colorectal hepatic metastases. Dis Colon Rectum 1988;31:100-103.
39. Nabi HA, Doerr RJ: Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: Current status and future perspectives. Am J Surg 1992;163: 448-456.
40. Doerr RJ, Abdel-Nabi H, Merchant B: Indium-111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level. Arch Surg 1990;125:226-229.
41. Beatty JD, Williams LW, Yamauchi D, et al: Presurgical imaging with indium-labeled anti-carcinoembryonic antigen for colon cancer staging. Cancer Res 1990;50(suppl): 922-926.
42. Patt YZ, Podoloff DA, Curley S, et al: Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels. J Clin Oncol 1994;12:489-495.
43. Babineau TJ, Lewis WD, Jenkins RL, Bleday R, et al: Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg 1994; 167:151-155.
44. Solomon MJ, Stephen MS, Gallinger S, White GH: Does intraoperative hepatic ultrasonography change surgical decision making during liver resection? Am J Surg 1994;168: 307-310.
45. Cohen AM, Martin EW, Lavery I, et al: Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer. Arch Surg 1991;126:349-352.
46. Turnbull ADM, Guerra J, Starnes HF: Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin. J Clin Oncol 1989;7:381-386.
47. Yeatman TJ, Bland KI, Copeland EM, et al: Relationship between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg 1989;210:505-512,
48. Uchino R, Kanemitsu K, Obayashi H, et al: Carcinoembryomc antigen (CEA) and CEA-related substances in the bile of patients with biliary diseases. Am J Surg 1994;167:306-308.